220 related articles for article (PubMed ID: 36544659)
1. Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study.
Qiu X; Gao J; Yang J; Hu J; Hu W; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1193. PubMed ID: 36544659
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
Ma N; Ming X; Chen J; Wu KL; Lu J; Jiang G; Mao J
Radiat Oncol; 2023 Dec; 18(1):195. PubMed ID: 38041122
[TBL] [Abstract][Full Text] [Related]
3. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
4. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
[TBL] [Abstract][Full Text] [Related]
6. Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.
Kong L; Wu J; Gao J; Qiu X; Yang J; Hu J; Hu W; Mao Y; Lu JJ
Cancer; 2020 Jun; 126(12):2802-2810. PubMed ID: 32167589
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
8. Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2).
Ferro M; Ferro M; Macchia G; Cilla S; Buwenge M; Re A; Romano C; Boccardi M; Picardi V; Cammelli S; Cucci E; Mignogna S; Di Lullo L; Valentini V; Morganti AG; Deodato F
Front Oncol; 2020; 10():626400. PubMed ID: 33692944
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
10. Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.
Sun J; Wang Z; Sheng Y; Ming X; Jiang GL; Wang W
Strahlenther Onkol; 2022 Apr; 198(4):361-369. PubMed ID: 34618172
[TBL] [Abstract][Full Text] [Related]
11. Treatment of high-grade gliomas using escalating doses of hypofractionated simultaneous integrated boost-intensity-modulated radiation therapy in combination with temozolomide: A modified Phase I clinical trial.
Ge X; Xue X; Liu H; Wang Y; Xiao Z; Tian L; Chang X; Lin Q; Yu J
J Cancer Res Ther; 2018; 14(7):1482-1491. PubMed ID: 30589027
[TBL] [Abstract][Full Text] [Related]
12. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
13. Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G; Tsuji H; Nomiya T; Makishima H; Haruyama Y; Kobashi G; Hayashi K; Ebner DK; Omatsu T; Kishimoto R; Yasuda S; Igarashi T; Oya M; Akakura K; Suzuki H; Ichikawa T; Shimazaki J; Kamada T;
Oncotarget; 2019 Jan; 10(1):76-81. PubMed ID: 30713604
[TBL] [Abstract][Full Text] [Related]
14. Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies.
Yang J; Gao J; Hu J; Hu W; Qiu X; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1200. PubMed ID: 36544688
[TBL] [Abstract][Full Text] [Related]
15. Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.
Eberle F; Engenhart-Cabillic R; Schymalla MM; Dumke C; Schötz U; Subtil FSB; Baumann KS; Stuck BA; Langer C; Jensen AD; Hauswald H; Lautenschläger S
Front Oncol; 2022; 12():814082. PubMed ID: 35242709
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
[TBL] [Abstract][Full Text] [Related]
17. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
[TBL] [Abstract][Full Text] [Related]
18. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
19. Comparison of carbon ion and photon reirradiation for recurrent glioblastoma.
Lautenschlaeger FS; Dumke R; Schymalla M; Hauswald H; Carl B; Stein M; Keber U; Jensen A; Engenhart-Cabillic R; Eberle F
Strahlenther Onkol; 2022 May; 198(5):427-435. PubMed ID: 34523017
[TBL] [Abstract][Full Text] [Related]
20. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
